Prevalence and risk factors for HIV, hepatitis B, and hepatitis C in people with severe mental illness: a total population study of Sweden.

scientific article published on 4 July 2017

Prevalence and risk factors for HIV, hepatitis B, and hepatitis C in people with severe mental illness: a total population study of Sweden. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S2215-0366(17)30253-5
P932PMC publication ID5573766
P698PubMed publication ID28687481

P50authorGlyn LewisQ5572854
David OsbornQ38644591
Joseph HayesQ86116312
P2093author name stringChristina Dalman
Lena Jörgensen
Clarissa Bauer-Staeb
P2860cites workHepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and preventionQ27014761
Sexual health risk reduction interventions for people with severe mental illness: a systematic review.Q28082492
How can I deal with missing data in my study?Q30664779
HIV/AIDS surveillance in Denmark: the challenges ahead.Q35061665
Recording of severe mental illness in United Kingdom primary care, 2000-2010.Q35070219
Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness: a systematic review and meta-analysisQ35856205
Schizophrenia and comorbid human immunodeficiency virus or hepatitis C virus.Q36233486
HIV risk behavior among patients with co-occurring bipolar and substance use disorders: associations with mania and drug abuseQ36488694
Extent of illicit drug use and dependence, and their contribution to the global burden of diseaseQ37973812
An empirical literature review of definitions of severe and persistent mental illnessQ37996806
Historical epidemiology of hepatitis C virus (HCV) in selected countries.Q38203033
Risk factors for HIV, hepatitis B, and hepatitis C among persons with severe mental illnessQ39650615
Hepatitis C virus and HIV co-infection in people with severe mental illness and substance use disordersQ39734484
Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors.Q39920086
Evaluation of diagnostic procedures in Swedish patients with schizophrenia and related psychosesQ40368967
The cost-effectiveness of harm reductionQ41457994
Enhanced surveillance of hepatitis B in the EU, 2006-2012.Q41651906
Hepatitis B prevalence in Denmark - an estimate based on nationwide registers and a national screening programme, as on 31 December 2007.Q42238216
The epidemiology of hepatitis C virus infection in SwedenQ45391712
Assessment and treatment of physical health problems among people with schizophrenia: national cross-sectional study.Q50617400
How is stigmatization affected by the "layering" of stigmatized conditions, such as serious mental illness and HIV?Q51933845
Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness.Q51969974
2013 UK national guideline for consultations requiring sexual history taking. Clinical Effectiveness Group British Association for Sexual Health and HIV.Q54523233
Life expectancy among persons with schizophrenia or bipolar affective disorderQ59652180
Increased rates of psychosis among immigrants to Sweden: is migration a risk factor for psychosis?Q73880631
Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide community-based register studyQ81041130
Increase of reported HIV infections in SwedenQ81295929
P433issue9
P921main subjectSwedenQ34
P304page(s)685-693
P577publication date2017-07-04
P1433published inThe Lancet PsychiatryQ27118886
P1476titlePrevalence and risk factors for HIV, hepatitis B, and hepatitis C in people with severe mental illness: a total population study of Sweden
P478volume4

Reverse relations

cites work (P2860)
Q89530640Adverse events in psychiatry: a national cohort study in Sweden with a unique psychiatric trigger tool
Q92237454Association between maternal serious mental illness and adverse birth outcomes
Q64298937Association of Hydroxylmethyl Glutaryl Coenzyme A Reductase Inhibitors, L-Type Calcium Channel Antagonists, and Biguanides With Rates of Psychiatric Hospitalization and Self-Harm in Individuals With Serious Mental Illness
Q92032761Common mental disorders: falling through the gap
Q47674319Ending HIV, hepatitis B, and hepatitis C: what about people with severe mental illness?
Q47593919HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome
Q47133962Lower risk of liver cancer in patients with schizophrenia: a systematic review and meta-analysis of cohort studies
Q62486334Occupational justice and social inclusion in mental illness and HIV: a scoping review protocol
Q92712616Syndemic Characterization of HCV, HBV, and HIV Co-infections in a Large Population Based Cohort Study

Search more.